Industry Insights - Archive

The pharmaceutical industry has no shortage of AI ambitions. Between now and 2030, AI investments are expected to skyrocket from $4B to $25B. Most of that spending is heading toward well-publicized Gen AI applications like drug discovery, clinical trial optimization, and automating back-office workflows.